Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Ceska Gynekol ; 84(3): 172-176, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31324105

RESUMEN

OBJECTIVE: To evaluate the risk of involvement of sentinel lymph nodes in cervical cancer stage IA1 with lymphovascular space invasion and IA2 using the detection of sentinel lymph nodes. DESIGN: Original article. SETTINGS: Department of Gynecology and Obstetrics 3rd Faculty of Medicine, Charles University, Faculty Hospital Královské Vinohrady, Prague; Oncogynecological centrum; Department of Pathology 3rd Faculty of Medicine, Charles University, Faculty Hospital Kralovské Vinohrady, Prague. METHODS: The study included women from prospective protocols LAP I and LAP II with cervical cancer stage IA1 with lymphovascular space invasion and stage IA2 from 2002 to 2018 classified according to FIGO 2014 staging, TNM 8. Detection of sentinel lymph nodes throughout this period was performed using ultra-short protocol with Tc and patent blau and also by histopathological examination. RESULTS: In the first group (28 women) with stage IA1 and lymphovascular space invasion diagnosed from cone biopsy there were two women with positive lymph nodes (7.1%). In the group stage IA2 (34 women) there were 13 women (38.2%) with positive lymphovascular space invasion and two women had positive lymph nodes (5.9%). The risk of positive lymph nodes for stage IA1 with lymphovascular space invasion and for stage IA2 is not statistically significant OR = 0.8125 (95% CI 0.1070-6.172). CONCLUSION: The detection of sentinel lymph nodes aids to individualize the therapy of early stage cervical cancer and helps to reduce the radicalization of surgery. The risk of positive lymph nodes in stage IA1 with lymphovascular space invasion and stage IA2 with/without lymphovascular space invasion is the same. The results confirm, that the detection of sentinel lymph nodes in stage IA1 with lymphovascular space invasion is fully indicated.


Asunto(s)
Biopsia del Ganglio Linfático Centinela , Ganglio Linfático Centinela/patología , Neoplasias del Cuello Uterino/patología , Femenino , Humanos , Escisión del Ganglio Linfático , Metástasis Linfática , Estadificación de Neoplasias , Estudios Prospectivos , Neoplasias del Cuello Uterino/cirugía
2.
Ceska Gynekol ; 84(6): 418-424, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31948249

RESUMEN

OBJECTIVE: To analyse own set of molar pregnancies and to develop clinically relevant procedures. TYPE OF STUDY: Review article with analysis of own data. SETTINGS: Department of Pathology 3rd Faculty of Medicine, Charles University, Faculty Hospital Královské Vinohrady, Prague; Department of Obstetrics and Gynecology 3rd Faculty of Medicine, Charles University, Faculty Hospital Královské Vinohrady, Prague. INTRODUCTION: The study monitors the decrease of laboratory values of beta-subunit of hCG gonadotropin (beta-hCG) after evacuation of partial and complete hydatidiform moles in a set of 45 partial and 46 complete moles. Two case reports of invasive moles. RESULTS: In cases of partial hydatidiform moles there was complete regression of beta-hCG in all cases, 89% regressed in six weeks, none of the women showed no subsequent elevation after reaching negativity. In cases of complete hydatidiform moles the decrease was less gradual, the negativity after six weeks was confirmed in 78%, three complete moles became malignant. CONCLUSION: The decrease of beta-hCG after molar pregnancy termination is variable. Even if in cases of complete hydatidiform moles the risk of malignization after reaching negativity is low, beta-hCG checks are recommended at monthly intervals for 6 months. Correct diagnosis of complete mole and its differentiation from partial mole can be achieved using immunohistochemistry - p57 antibody.


Asunto(s)
Aborto Inducido , Gonadotropina Coriónica Humana de Subunidad beta/sangre , Mola Hidatiforme Invasiva/patología , Neoplasias Uterinas/patología , Femenino , Humanos , Mola Hidatiforme Invasiva/sangre , Mola Hidatiforme Invasiva/cirugía , Inmunohistoquímica , Embarazo , Neoplasias Uterinas/sangre , Neoplasias Uterinas/cirugía
3.
Klin Onkol ; 38(4): 250-258, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39174328

RESUMEN

BACKGROUND: International Federation of Gynaecology and Obstetrics (Fédération Internationale de Gynécologie et d'Obstétrique - FIGO) introduced a new staging system for endometrial carcinoma - FIGO 2023 - in June 2023. OBJECTIVE: The new staging system differs significantly from previous versions. The new system represents a significant departure from the traditional staging systems for other gynaecological cancers, as the definition of individual stages includes not only the traditional anatomical extent of the tumour, but also the molecular profile of the tumour and other histopathological parameters - histological type of tumour, tumour grade and the presence of substantial lymphovascular invasion. The new system defines stages I and II in a completely different way and expands the definition of stages III and IV, allowing for different types of tumour spread outside the uterus. The introduction of molecular testing is the main change in the new staging system. When certain molecular markers are detected, stage I or II is completely changed. By including these non-anatomical parameters, the FIGO 2023 staging system improves the accuracy of a patient's prognosis at a specific stage with better options for individualized treatment, including the use of immunotherapy. Another goal was to synchronise staging as much as possible with the recommendations of three professional societies: the European Society of Gynaecological Oncology (ESGO), the European Society for Radiotherapy and Oncology (ESTRO) and the European Society of Pathology (ESP). The staging system for carcinosarcoma remains identical to the staging system for endometrial cancer. CONCLUSION: This article presents an overview of the new FIGO 2023 endometrial cancer staging system and discusses its advantages and disadvantages for clinical practice.


Asunto(s)
Neoplasias Endometriales , Estadificación de Neoplasias , Humanos , Neoplasias Endometriales/patología , Neoplasias Endometriales/terapia , Femenino
4.
Cesk Patol ; 44(1): 20-2, 2008 Jan.
Artículo en Cs | MEDLINE | ID: mdl-18333330

RESUMEN

The authors present two cases of primary synovial sarcoma of the kidney. Both patients had a tumor mass in the kidney with vascular invasion of the inferior vena cava and right atrium of the heart in case no. 1. In case no. 2 retroperitoneal lymph node metastasis and multiple metastases to both lungs were observed. Radical nephrectomies were performed in both patients. Histologically, the tumor in case no. 1 was monophasic and in case no. 2 poorly differentiated. Immunohistochemically, vimentin was diffusely positive and a few tumor cells were positive for epithelial membrane antigen. The tumor cells were negative for keratins, S- 100 protein, CD 34, smooth muscle actin, and desmin. In both cases, reverse transcription-polymerase chain reaction using ribonucleic acid extracted from formalin-fixed, paraffin-embedded tissues detected SYT-SSX 1 fusion gene transcripts, which are characteristic molecular findings of synovial sarcoma.


Asunto(s)
Neoplasias Renales/patología , Sarcoma Sinovial/patología , Adulto , Femenino , Humanos , Inmunohistoquímica , Neoplasias Renales/química , Masculino , Persona de Mediana Edad , Invasividad Neoplásica , Sarcoma Sinovial/química
5.
Cesk Patol ; 42(1): 20-3, 2006 Jan.
Artículo en Cs | MEDLINE | ID: mdl-16506597

RESUMEN

Persistence of high-risk types of human papillomavirus (HPV) is responsible for the development, maintenance and progression of squamous intraepithelial lesions (SILs). Cytohistologic correlation with the results of the HPV testing in 52 patients over a 3year period is presented. Two patients out of the 52 patients presented in this histologic follow up bore the diagnosis high-grade squamous intraepithelial lesion (HSIL) with the former cytology ASC-H. Low grade squamous intraepithelial lesions (LSIL) were found in eight patients, half of them diagnosed identically on cytology. Another four cases were formerly diagnosed cytologically as ASC-US. All women with the histologically confirmed dysplastic changes were HR HPV DNA positive. Our results indicate that significant histologic lesions may be discovered in patients exhibiting the high-risk HPV DNA positivity in the category of ASC-US (Atypical Squamous Cells of Undetermined Significance) and especially ASC-H (ASC cannot exclude high-grade squamous intraepithelial lesion). A combined screening test thus offers the possibility of greater protection and /or longer screening intervals.


Asunto(s)
Papillomaviridae , Infecciones por Papillomavirus/diagnóstico , Lesiones Precancerosas/diagnóstico , Displasia del Cuello del Útero/diagnóstico , Adulto , Anciano , Femenino , Humanos , Persona de Mediana Edad , Infecciones por Papillomavirus/complicaciones , Lesiones Precancerosas/patología , Lesiones Precancerosas/virología , Displasia del Cuello del Útero/virología , Neoplasias del Cuello Uterino/diagnóstico , Neoplasias del Cuello Uterino/virología
6.
Epidemiol Mikrobiol Imunol ; 49(2): 51-8, 2000 Apr.
Artículo en Cs | MEDLINE | ID: mdl-10838776

RESUMEN

The authors investigated 352 strains of coagulase-negative staphylococci isolated from hemo-cultures of patients with assumed bacteraemia who were hospitalized in standard hospital departments and intensive care units. The strains were identified using STAPHYtest 16 and 14 different species and subspecies of coagulase-negative staphylococci were found. Most frequent were strains of Staphylococcus epidermidis (53%), strains of S. hominis subsp. hominis (22%) and S. haemolyticus (13%). In the strains the production of slime and delta-haemolysin was investigated. The formation of these two important factors of virulence was recorded in 95% strains (incl. major slime production in 13.4%), and 50% strains resp. The resistance to 13 antibiotics was also assessed. A total of 91% strains were resistant to penicillin, 63% to oxacillin and amoxicillin with clavulanic acid, 67% to gentamicin and 66% to erythromycin. In the group 15 strains of a recently described subspecies S. hominis subsp. novobiosepticus was identified. These isolates displayed most frequently resistance: they were resistant in 100% to five antibiotics (penicillin, oxacillin, erythromycin, clindamycin and amoxicillin with clavulanic acid) and with a single exception to another three antibiotics (chloramphenicol, gentamicin and ciprofloxacin). In these strains most frequently slime as well as delta-haemolysin was found. The authors assume, consistent with previous work, that it is important to focus attention on the incidence of strains of S. hominis subsp. novobiosepticus which very probably play an important role as agents in hospital infections. The authors describe also detection of one strain of S. cohnii subsp. urealyticum which was resistant to 10 of 13 antibiotics. The authors are convinced that also classical phenotypic analysis can contribute in an effective manner to the solution of the problem of infections caused by coagulase-negative staphylococci.


Asunto(s)
Bacteriemia/microbiología , Coagulasa/biosíntesis , Infecciones Estafilocócicas/microbiología , Staphylococcus/clasificación , Farmacorresistencia Microbiana , Humanos , Staphylococcus/efectos de los fármacos , Staphylococcus/metabolismo
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda